Crewe Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,597
| Closed | -$883K | – | 974 |
|
|
2024
Q2 | $883K | Sell |
1,597
-18
| -1% | -$9.95K | 0.1% | 74 |
|
|
2024
Q1 | $939K | Buy |
+1,615
| New | +$939K | 0.11% | 72 |
|
|
2023
Q3 | – | Sell |
-1,419
| Closed | -$740K | – | 882 |
|
|
2023
Q2 | $740K | Buy |
1,419
+247
| +21% | +$129K | 0.1% | 63 |
|
|
2023
Q1 | $676K | Sell |
1,172
-39
| -3% | -$22.5K | 0.1% | 68 |
|
|
2022
Q4 | $667K | Sell |
1,211
-88
| -7% | -$48.5K | 0.11% | 67 |
|
|
2022
Q3 | $659K | Buy |
1,299
+290
| +29% | +$147K | 0.12% | 61 |
|
|
2022
Q2 | $548K | Buy |
1,009
+402
| +66% | +$218K | 0.12% | 54 |
|
|
2022
Q1 | $358K | Buy |
607
+255
| +72% | +$150K | 0.07% | 70 |
|
|
2021
Q4 | $235K | Buy |
352
+1
| +0.3% | +$668 | 0.05% | 76 |
|
|
2021
Q3 | $201K | Sell |
351
-8
| -2% | -$4.58K | 0.05% | 68 |
|
|
2021
Q2 | $181K | Sell |
359
-11
| -3% | -$5.55K | 0.04% | 76 |
|
|
2021
Q1 | $169K | Buy |
370
+7
| +2% | +$3.2K | 0.04% | 72 |
|
|
2020
Q4 | $169K | Buy |
363
+43
| +13% | +$20K | 0.07% | 69 |
|
|
2020
Q3 | $141K | Buy |
320
+83
| +35% | +$36.6K | 0.07% | 63 |
|
|
2020
Q2 | $86K | Buy |
237
+19
| +9% | +$6.9K | 0.04% | 83 |
|
|
2020
Q1 | $62K | Hold |
218
| – | – | 0.04% | 78 |
|
|
2019
Q4 | $71K | Sell |
218
-431
| -66% | -$140K | 0.03% | 94 |
|
|
2019
Q3 | $189K | Sell |
649
-850
| -57% | -$248K | 0.09% | 59 |
|
|
2019
Q2 | $440K | Buy |
1,499
+892
| +147% | +$262K | 0.14% | 42 |
|
|
2019
Q1 | $166K | Buy |
607
+387
| +176% | +$106K | 0.05% | 64 |
|
|
2018
Q4 | $49K | Hold |
220
| – | – | 0.02% | 111 |
|
|
2018
Q3 | $54K | Sell |
220
-80
| -27% | -$19.6K | 0.05% | 115 |
|
|
2018
Q2 | $62K | Buy |
300
+149
| +99% | +$30.8K | 0.06% | 104 |
|
|
2018
Q1 | $31K | Hold |
151
| – | – | 0.03% | 153 |
|
|
2017
Q4 | $29K | Buy |
+151
| New | +$29K | 0.03% | 165 |
|